Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome. [electronic resource]
Producer: 20020403Description: 310-5 p. digitalISSN:- 0887-6924
- Acute Disease
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cytarabine -- administration & dosage
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Humans
- Leukemia, Myeloid -- drug therapy
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Survival Rate
- Thrombocytopenia -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.